Cyclosporine A inhibits transcription of cytokine genes and decreases the frequencies of IL-2 producing cells in feline mononuclear cells

Journal of Veterinary Medical Science

Volumn 70, Issue 10, 2008, Pages 1011-1016

  Kuga, Kazufumi ^a   Nishifuji, Koji ^a   Iwasaki, Toshiroh ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Allergic dermatitis; Cyclosporine A; Cytokines; ELISPOT; Feline

Indexed keywords

CYCLOSPORIN; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; BLOOD; CAT; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; MONONUCLEAR CELL; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CATS; CYCLOSPORINE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

CANIS FAMILIARIS; FELIDAE; MUS;

EID: 55749084705     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.70.1011     Document Type: Article

References (36)

1. Andersson, J., Nagy, S., Groth, C. G. and Andersson, U. 1992. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology 75: 136-142.
2. Bernsteen, L., Gregory, C. R., Kyles, A. E., Wooldridge, J. D. and Valverde, C. R. 2000. Renal transplantation in cats. Clin. Tech. Small. Anim. Pract. 15: 40-45.
3. Borel, J. F., Feurer, C., Gubler, H. U. and Stahelin, H. 1976. Biological effects of cyclosporine A: a new antilymphocytic agent. Agents Actions 43: 179-186.
4. Boulet, S., Ndongala, M. L., Peretz, Y., Boisvert, M. P., Boulassel, M. R., Tremblay, C., Routy, J. P., Sekaly, R. P. and Bernard, N. F. 2007. A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses. J. Immunol. Methods 320: 18-29.
5. Cox, JH., Ferrari, G. and Janetzki, S. 2006. Measurement of cytokine release at the single cell level using the ELISPOT assay. Methods 38: 274-282.
6. Dean, G. A., LaVoy, A. and Burkhard, M. J. 2004. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT. Vet. Immunol. Immunopathol. 100: 49-59.
7. Dos Reis, G. A. and Shevach, E. M. 1982. Effect of cyclosporin A on T cell function in vitro: the mechanism of suppression of T cell proliferation depends on the nature of the T cell stimulus as well as the differentiation state of the responding T cell. J. Immunol. 129: 2360-2367.
8. Goldfeld, A. E., McCaffrey, P. G., Strominger, J. L. and Rao, A. 1993. Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter. J. Exp. Med. 178: 1365-1379.
9. Grewe, M., Bruijnzeel-Koomen, C. A., Schöpf, E., Thepen, T., Langeveld-Wildschut, A. G., Ruzicka, T. and Krutmann, J. 1998. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today 19: 359-361.
10. Griffiths, C. E., Katsambas, A., Dijkmans, B. A., Finlay, A. Y., Ho, V. C., Johnston, A., Luger, T. A., Mrowietz, U. and Thestrup-Pedersen, K. 2006. Update on the use of ciclosporin in immune-mediated dermatoses. Br. J. Dermatol. 155 (Suppl. 2):1-16.
11. Hijnen, D. J., ten Berge, O., Timmer-de Mik, L., Bruijnzeel-Koomen, C. A. and de Bruin-Weller. M. S. 2007. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis. J. Eur. Acad. Dermatol. 21: 85-89.
12. Iwai, S., Endo, K., Hakamata, Y., Gregory, C. R. and Kobayashi, E. 2006. Use of nonpenetrating vascular closure staples in feline renal transplantation. Microsurgery 26: 13-16.
13. Kenneth, M., Paul, T. and Mark, W. 2008. Immunology, 7th ed., Garland Science, New York.
14. Kiani, A., Rao, A. and Aramburu, J. 2000. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 12: 359-372.
15. Kobayashi, T., Momoi, Y. and Iwasaki, T. 2007. Cyclosporine A inhibits the mRNA expressions of IL-2, IL-4 and IFN-gamma, but not TNF-alpha, in canine mononuclear cells. J. Vet. Med. Sci. 69: 887-892.
16. Leung, D. Y., Boguniewicz, M., Howell, M. D., Nomura, I. and Hamid, Q. A. 2004. New insights into atopic dermatitis. J. Clin. Invest. 113: 651-657.
17. Matsuda, S. and Koyasu, S. 2000. Mechanisms of action of cyclosporine. Immunophamarcology 47: 119-125.
18. McAnulty, J. F. and Lensmeyer, G. L. 1999. The effects of ketoconazole on the pharmacokinetics of cyclosporine A in cats. Vet. Surg. 28: 448-455.
19. Nagai, H., Hiyama, H., Matsuo, A., Ueda, Y., Inagaki, N. and Kawada, K. 1997. FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice. J. Pharmacol. Exp. Ther. 283: 321-327.
20. Nash, P. T. and Florin, T. H. 2005. Tumour necrosis factor inhibitors. Med. J. Aust. 183: 205-208.
21. Noli, C. and Scarampella, F. 2006. Prospective open pilot study on the use of cyclosporin for feline allergic skin disease. J. Small. Anim. Pract. 47: 434-438.
22. Olivry, T., Rivierre, C., Jackson, H. A., Murphy, K. M., Davidson, G. and Sousa, C. A. 2002. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial. Vet. Dermatol. 13: 77-87.
23. Payne, J. A., Herrod, H. G. and Buice, R. 1986. The effect of cyclosporine on canine lymphocyte activity. J. Clin. Lab. Immunol. 20: 177-181.
24. Plevy, SE., Landers, CJ., Prehn, J., Carramanzana, NM., Deem, RL., Shealy, D. and Targan, S. R. 1997. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J. Immunol. 159: 6276-6282.
25. Rao, A., Luo, C. and Hogan, P. G. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15: 707-747.
26. Ridyard, A. E., Nuttall, T. J., Else, R. W., Simpson, J. W. and Miller, H. R. 2002. Evaluation of Th1, Th2 and immunosuppressive cytokine mRNA expression within the colonic mucosa of dogs with idiopathic lymphocytic-plasmacytic colitis. Vet. Immunol. Immunopathol. 86: 205-214.
27. Roosje, P. J., Dean, G. A., Willemse, T., Rutten, V. P. and Thepen, T. 2002. Interleukin 4-producing CD4+ T cells in the skin of cats with allergic dermatitis. Vet. Pathol. 39: 228-233.
28. Roosje, P. J., van Kooten, P. J., Thepen, T., Bihari, I. C., Rutten, V. P., Koeman, J. P., and Willemse, T. 1998. Increased numbers of CD4+ and CD8+ T cells in lesional skin of cats with allergic dermatitis. Vet. Pathol. 35: 268-273.
29. Rovira, P., Mascarell, L. and Truffa-Bachi, P. 2000. The impact of immunosuppressive drugs on the analysis of T cell activation. Curr. Med. Chem. 7: 673-692.
30. Steffan, J., Favrot, C. and Mueller, R. 2006. A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs. Vet. Dermatol. 17: 3-16.
31. Takaori, K., Nio, Y., Inoue, K., Tun, T., Fukumoto, M., Hashida, T., Yasuhara, M., Hori, R. and Tobe, T. 1992. A comparative study on immunosuppressive effects of cyclosporin A and FK 506 on peripheral blood lymphocytes in dogs. Biotherapy 4: 129-137.
32. Tanguay, S. and Killion, J. J. 1994. Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells. Lymphokine. Cytokine. Res. 13: 259-263.
33. Taqlinqer, K., Day, M. J. and Foster, A. P. 2007. Characterization of inflammatory cell infiltration in feline allergic skin disease. J. Comp. Pathol. 137: 211-223.
34. Vercelli, A., Raviri, G. and Cornegliani, L. 2006. The use of oral cyclosporin to treat feline dermatoses: a retrospective analysis of 23 cases. Vet. Dermatol. 17: 201-206.
35. Yoshimura, N., Matsui, S., Hamashima, T. and Oka, T. 1988. Alloreactive suppressor T cells and cytokine (gamma-IFN, interleukin 1, 2, and 3) production in cyclosporine- treated mice. Transplant. Proc. 20: 1016-1024.
36. Yoshimura, N., Okamoto, M., Akioka, K. and Kaihara, S. 2004. Optimization of the use of cyclosporine in renal transplantation. Transplant. Proc. 36: 181S-185S.